Your browser doesn't support javascript.
loading
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy.
Sweeney, Sedona; Gomez, Gabriela; Kitson, Nichola; Sinha, Animesh; Yatskevich, Natalia; Staples, Suzanne; Moodliar, Ronelle; Motlhako, Sharon; Maloma, Matshepo; Rassool, Mohammed; Ngubane, Nosipho; Ndlovu, Ella; Nyang'wa, Bern-Thomas.
Afiliação
  • Sweeney S; Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK sedona.sweeney@lshtm.ac.uk.
  • Gomez G; Vaccine Epidemiology and Modelling, Sanofi Pasteur SA, Lyon, France.
  • Kitson N; Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
  • Sinha A; Médecins Sans Frontières Holland, Minsk, Belarus.
  • Yatskevich N; Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.
  • Staples S; TB and HIV Investigative Network (THINK), Durban, South Africa.
  • Moodliar R; TB and HIV Investigative Network (THINK), Durban, South Africa.
  • Motlhako S; Helen Joseph Hospital, Clinical HIV Research Unit, Wits Health Consortium, University of the Witwatersrand, Johannesburg, South Africa.
  • Maloma M; King DinuZulu Hospital, Clinical HIV Research Unit, Wits Health Consortium, University of the Witwatersrand, Durban, South Africa.
  • Rassool M; Helen Joseph Hospital, Clinical HIV Research Unit, Wits Health Consortium, University of the Witwatersrand, Johannesburg, South Africa.
  • Ngubane N; King DinuZulu Hospital, Clinical HIV Research Unit, Wits Health Consortium, University of the Witwatersrand, Durban, South Africa.
  • Ndlovu E; King DinuZulu Hospital, Clinical HIV Research Unit, Wits Health Consortium, University of the Witwatersrand, Durban, South Africa.
  • Nyang'wa BT; Manson Unit, Médecins Sans Frontières, London, UK.
BMJ Open ; 10(10): e036599, 2020 10 10.
Article em En | MEDLINE | ID: mdl-33039989

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Antituberculosos Tipo de estudo: Guideline / Health_economic_evaluation / Risk_factors_studies Limite: Humans País/Região como assunto: Africa / Asia / Europa Idioma: En Revista: BMJ Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Antituberculosos Tipo de estudo: Guideline / Health_economic_evaluation / Risk_factors_studies Limite: Humans País/Região como assunto: Africa / Asia / Europa Idioma: En Revista: BMJ Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido